| SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates GA Poland, IG Ovsyannikova, RB Kennedy The Lancet 396 (10262), 1595-1606, 2020 | 685 | 2020 |
| Immunosenescence and human vaccine immune responses SN Crooke, IG Ovsyannikova, GA Poland, RB Kennedy Immunity & ageing 16, 1-16, 2019 | 431 | 2019 |
| Senescent cell clearance by the immune system: Emerging therapeutic opportunities LGPL Prata, IG Ovsyannikova, T Tchkonia, JL Kirkland Seminars in immunology 40, 101275, 2018 | 374 | 2018 |
| Fine mapping causal variants with an approximate Bayesian method using marginal test statistics W Chen, BR Larrabee, IG Ovsyannikova, RB Kennedy, IH Haralambieva, ... Genetics 200 (3), 719-736, 2015 | 240 | 2015 |
| Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics GA Poland, IG Ovsyannikova, RM Jacobson, DI Smith Clinical Pharmacology & Therapeutics 82 (6), 653-664, 2007 | 235 | 2007 |
| The role of host genetics in the immune response to SARS‐CoV‐2 and COVID‐19 susceptibility and severity IG Ovsyannikova, IH Haralambieva, SN Crooke, GA Poland, RB Kennedy Immunological reviews 296 (1), 205-219, 2020 | 230 | 2020 |
| The weight of obesity on the human immune response to vaccination SD Painter, IG Ovsyannikova, GA Poland Vaccine 33 (36), 4422-4429, 2015 | 208 | 2015 |
| Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results N Dhiman, IG Ovsyannikova, RA Vierkant, JE Ryan, VS Pankratz, ... Vaccine 26 (14), 1731-1736, 2008 | 188 | 2008 |
| Influenza virus resistance to antiviral agents: a plea for rational use GA Poland, RM Jacobson, IG Ovsyannikova Clinical infectious diseases 48 (9), 1254-1256, 2009 | 187 | 2009 |
| Personalized vaccinology: a review GA Poland, IG Ovsyannikova, RB Kennedy Vaccine 36 (36), 5350-5357, 2018 | 186 | 2018 |
| Development of vaccines against Zika virus GA Poland, RB Kennedy, IG Ovsyannikova, R Palacios, PL Ho, J Kalil The Lancet Infectious Diseases 18 (7), e211-e219, 2018 | 178 | 2018 |
| Personalized vaccines: the emerging field of vaccinomics GA Poland, IG Ovsyannikova, RM Jacobson Expert opinion on biological therapy 8 (11), 1659-1667, 2008 | 169 | 2008 |
| Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach ND Lambert, IG Ovsyannikova, VS Pankratz, RM Jacobson, GA Poland Expert review of vaccines 11 (8), 985-994, 2012 | 165 | 2012 |
| Prevalence and morbidity of undiagnosed celiac disease from a community-based study SA Larson, S Khaleghi, A Rubio-Tapia, IG Ovsyannikova, KS King, ... Gastroenterology 152 (4), 830-839. e5, 2017 | 162 | 2017 |
| Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics GA Poland, RM Jacobson, IG Ovsyannikova Vaccine 27 (25-26), 3240-3244, 2009 | 162 | 2009 |
| SARS-CoV-2 vaccine development: current status GA Poland, IG Ovsyannikova, SN Crooke, RB Kennedy Mayo Clinic Proceedings 95 (10), 2172-2188, 2020 | 153 | 2020 |
| Application of pharmacogenomics to vaccines GA Poland, IG Ovsyannikova, RM Jacobson Future Medicine Ltd 10 (5), 837-852, 2009 | 153 | 2009 |
| Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery? GA Poland, RB Kennedy, IG Ovsyannikova PLoS pathogens 7 (12), e1002344, 2011 | 137 | 2011 |
| Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century GA Poland, RB Kennedy, BA McKinney, IG Ovsyannikova, ND Lambert, ... Seminars in immunology 25 (2), 89-103, 2013 | 128 | 2013 |
| Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses HIPC-CHI Signatures Project Team, HIPC-I Consortium Science immunology 2 (14), eaal4656, 2017 | 127 | 2017 |
